Amgen Inc Stock Investor Sentiment

AMGN Stock  USD 282.87  2.80  1.00%   
About 50% of Amgen's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Amgen Inc suggests that some traders are interested. Amgen's investing sentiment overview a quick insight into current market opportunities from investing in Amgen Inc. Many technical investors use Amgen Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

50

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Amgen's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Amgen Inc.

Amgen Historical Sentiment

Although Amgen's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Amgen, such as negative comments on social media and news outlets, may cause fear in the market and push Amgen's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Amgen.
  

Amgen Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Amgen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Amgen Inc Historical Investor Sentiment

Investor biases related to Amgen's public news can be used to forecast risks associated with an investment in Amgen. The trend in average sentiment can be used to explain how an investor holding Amgen can time the market purely based on public headlines and social activities around Amgen Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Amgen's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Amgen and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Amgen news discussions. The higher the estimate score, the more favorable the investor's outlook on Amgen.
a minute ago at zacks.com         
Amgen Inc. Is a Trending Stock Facts to Know Before Betting on It
zacks News
22 hours ago at thelincolnianonline.com         
Encompass More Asset Management Raises Holdings in Amgen Inc.
news
a day ago at investors.com         
Wide Trading Range For Amgen Stock Makes This Option Shine
Investors Business Daily at Macroaxis
a day ago at gurufocus.com         
Amgen Inc to Present at 7th Annual Evercore HealthCONx Conference
Gurufocus Stories at Macroaxis
2 days ago at finance.yahoo.com         
Should You Be Excited About Amgen Inc.s 56 percent Return On Equity?
Yahoo News
2 days ago at thelincolnianonline.com         
Zurcher Kantonalbank Zurich Cantonalbank Increases Stake in Amgen Inc.
news
2 days ago at finance.yahoo.com         
TEVA Stock Down 10 percent in a Month Should You Buy the Dip?
Yahoo News
3 days ago at investing.com         
Amgen stock holds Buy rating, TD Cowen highlights MariTides competitive edge in obesity treatment
Investing News at Macroaxis
3 days ago at finance.yahoo.com         
AMGN Stock Down Despite Strong Data From Obesity Drug Study
Yahoo News
3 days ago at thelincolnianonline.com         
BNP Paribas Trims Stock Holdings in Amgen Inc.
news
3 days ago at newsweek.com         
Amgen drug delivers more weight loss than competitors
news
few days ago at finance.yahoo.com         
Stock market today SP 500 eyes fresh record as Wall Street shrugs off Trumps tariff threat
Yahoo News
few days ago at medcitynews.com         
Weight Loss With Amgen Drug in Line With Eli Lilly Med, But Dosing Could Be Differentiator
news
few days ago at aol.com         
Fed officials see interest rate cuts ahead, but only gradually, meeting minutes show
news
few days ago at investing.com         
Amgen shares hold as Oppenheimer keeps 380 target
Investing News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Amgen that are available to investors today. That information is available publicly through Amgen media outlets and privately through word of mouth or via Amgen internal channels. However, regardless of the origin, that massive amount of Amgen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amgen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amgen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amgen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amgen alpha.

Amgen Performance against Dow Jones

 Price Growth (%)  
       Timeline  
 
Amgen dividend paid on 6th of September 2024
09/06/2024
1
Collegium names Vikram Karnani as CEO
11/07/2024
2
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTides Impact on Bone Density
11/13/2024
3
Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 and CT-P47 at American College of Rheu...
11/18/2024
4
Eli Lilly Option Trade Produces 1,125, If You Can Tolerate The Heavy Risk
11/20/2024
5
German American Bancorp Inc. Buys 100 Shares of Amgen Inc.
11/21/2024
6
Why Amgen is a Top Value Stock for the Long-Term
11/22/2024
7
Fed officials see interest rate cuts ahead, but only gradually, meeting minutes show
11/26/2024
8
AMGN Stock Down Despite Strong Data From Obesity Drug Study
11/27/2024
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.621
Dividend Share
8.88
Earnings Share
7.84
Revenue Per Share
60.641
Quarterly Revenue Growth
0.232
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.